Accessibility: Skip TopNav
SYNOVATE
SYNOVATE is a randomized, global Phase 3 trial to evaluate CMB305 immuontherapy in synovial sarcoma patients. www.synovatestudy.com
Format
JPEG
Source
Immune Design Corp.
Downloads
Original
Large
Medium
Small